性传播疾病防治项目实施指南

Size: px

Start display at page:

Download "性传播疾病防治项目实施指南"

袁宥窃印
7 years ago
Views:

2 STDHIV

4 - 2 -

5 - 3 -

6 247C

7 HIV - 5 -

8 HIV,,,,,,,,,,,,, - 6 -

9 ,

10 , - 8 -

11 - 9 -

13 2., RCT Quasi RCT quasi quasi quasi

14 1. STD, 3 2.CEA CEA CEA CEA PID CEA 3. (CUA) CUA CEA QALY QALY QALY STD QALY CUA 4. (CBA) CBA CEA CEA PID

15 CEA CUA

16 STD ,

17 CDC

18 - 16 -

19 3-17 -

20 9 HIV HIV HIV 1) 2) 3) 4) / 5) 6) 7) 8) 9) 10) 11) HIV 1) 2) 3)

21 4-19 -

22 4-20 -

25 / PTC RTC AETC 3 3 PTC RTC HIV AETC HIV

26 - STD

27 STD STD HIV STD STD STD STD 3 3 STD STD Pap HIV STD STD DIS HIV STD

28 1.5 HIV HIV HIV DIS DIS DIS STD

29 1 2 STD 3 4 STD DIS STD STD

30 STD HIV HIV STD STD AIDS HIV HIV Mantoux HIV HIV HIV STD HIV STD

31 STD 2 2 STD DIS STD/HIV STD CDC DIS STD DIS STD STD DIS

32 STD STD HIV STD HIV STD STD 100% STD STD 24 55% 8% 12%

33 STD STD STD STD STD HIV STD HIV STD HIV HIV HIV HIV HIV/AIDS HIV HIV STD HIV STD STD

34 STD HIV HIV STD STD STD STD STD STD

35 STD DIS DIS STD STD 7 STD STD

36 HIV HIV 1. DIS DIS 2. DIS STD - DIS 3. 3 STD

37 4. STD/HIV DIS HIV 6. DIS STDSTD STD STD

38 STD

39 DIS DIS NIH

40 (CID) 1989 (RECAP) RECAP RECAP RECAP

41 - 39 -

42 - 40 -

43 /HIV

44 HIV Respect 6 (WINGS) 3 (AESOP)

45 HIV HIV HIV CDC

46 STD STD/HIV

47 STD STD STD STD STD 25% STD STD STD STD / 48 DIS STD STD STD STD

48 STD STD HIV STD STD STD /STD STD STD STD STD STD STD HIV STD STD STD STD CDC STD STD STD STD STD STD

49 HMO MCO MCO STD MCO STD STD STD STD MCO STD MCO MCO MCO STD STD (HEDIS) STD STD STD

50 STD MCO STD STD CDC STD STD/HIV STD HIV HIV HIV STD HIV STD HIV STD STD HIV STD HIV STD HIV HIV HIV STD STD STD STD STD STD HIV STD HIV HIV STD HIV STD HIV (ACHSP) STD HIV STD HIV ACHSP STD HIV HIV STD

51 HIV STD HIV STD HMA HMA 5 PRA PRA PRA STD

52 HIV STD STD STD STD STD STD STD STD STD STD HIV Program operations guidelines for STD prevention,

53 20 STI STI STI STI STI HIV STI HIV STD HIV HIV 10 STI HIV-1 40% STI HIV STI Over Piot STI WHO STI

54 1 STI ( ) ( ) (1/1000) ( ) % 27% 70 75%

56 STI STD STI

57 STI STI WHO % % % % % 70% % 16% 31% 8% 13% 19% 6% 0.8% 3.2% 3% 9% 1% 0.8% WHO 2001 Global Prevalence and Incidence of Selected Curable Sexually Transmitted Infections: Overview and Estimates

58 % % % % % % % NGU NGU NGU

59 29.48% NGU 31.81% 24.11% 9.71% 4.43% 0.45% NGU

60 - 58 -

61 - 59 -

62 STDHIV HIV STD HIV STD STD HIV HIV STD STD HIV HIV STD STD HIV STD HIV Torian /10 194/10 HIV STD HIV 8% 5% HIV 11 12% 25 HIV 14 16% HIV HIV HIV Koumans 29 HIV HIV / 0 81/10 HIV HIV HIV Gray HIV Rakai STD HIV 8089 HIV 16% HIV HIV HIV STD STD STD STD HIV HIV STD STD HIV 370 Chaplinskas 1998 HIV HIV AIDS STD STD 101.4/

63 Dowe 339 NGU 5.2% HIV Tabrizi STD 6% 17 16% 47 1% 2 8% 24 HIV 1% % 16 STD STD STD HIV HIV STD HIV 58 3% HIV 11.3% HIV 88% 31% 4% STD AIDS Roy HIV % 31% 36.4% HIV 1.9% 20 HIV Feldman 599 HIV 2.0% 1.6% 18.8% 75% HIV 14.2 HIV Pitche STD ( ) 1 10 HIV HIV HIV STD

64 Severson HIV HIV HIV HIV HIV HIV HIV HIV Bordan 13 HIV RPR 8 RPR VDRL DNA Erbelding HIV STD HIV 58% % % 691 HIV 46% % 1.6% STD HIV STD STD HIV

65 - 63 -

66 - 64 -

67 STDs HIV(+) 837, % HIV Fox Pro 5.0 SPSS Fisher % 7/12 22% 2/

68 9 7 50% 6/12 PCR MDI 1 1. / (%) 11 (92) (89) (75) (89) (75) (89) (92) (89) (100) (100) (17) ( 0) (58) (22) (50) (78) (75) (89) (50) (89) (17) (56) (67) (100) (50) (89) (42) (89) (42) (89) 1 9 HIV 3 (25)

69 6 (67) (67) (100) (67) (100) 0 9 MDI/PCR 8 (67) (33) 6 9 MDI = PCR = % NGU % NGU P = % NGU % NGU P = NGU GH CA / NGU = GH = CA = NGU 89% 83% 44% 50% 40% 23% Fisher NGU

70 3. (%) P 1 8 (89) ( ) > 3000* 3 3 (50) ( ) 252** NGU 3 15 (83) ( ) > 3000* 3 2 (40) ( ) 190** CA 9 7 (44) ( ) > 4000* 23 7 (23) ( ) 359** NGU = CA = *. ** MDI PCR % 8 35% NGU % 1 4% NGU MDI PCR

71 1. 2. MDI

72 - 70 -

73 - 71 -

74 - 72 -

75 - 73 -

76 4-74 -

228次张建川全文和提要.doc

228次张建川全文和提要.doc 1 67.4 2010 1000 150 60 4000 5000 2 1 2 3 AIDS HIVHIV HIV HIV/AIDS 1981 20 HIV 2/3 82001 3460 66.5% 8.1% 21.0% 19921994 30 70100 7090 HIV 1 80 1996 42 300 400 10 1993 400 2 STD 70 1995 36.2 10 2000 35